Robert Brodsky

301 posts

Robert Brodsky banner
Robert Brodsky

Robert Brodsky

@DocsDock200

ASH President 2023 @ASH_Hematology. Chief of Hematology Johns Hopkins.

Maryland, USA Katılım Ekim 2022
353 Takip Edilen2.8K Takipçiler
Robert Brodsky
Robert Brodsky@DocsDock200·
@psharmaMD Avoid peripheral blood. More T cells in PBSCT than marrow (~1 log) - increases gvhd which only causes harm in no malignant dz like SCD or SAA
English
0
0
1
28
Robert Brodsky
Robert Brodsky@DocsDock200·
Game changer for #sicklecellamemia. doi.org/10.1182/blooda… Nonmyleoablative haploBMT with PTCy using Baltimore regimen (flu/cy/tbi400) rather than thiotepa. What are the advances? 1) 95% OS and 94% DFS @ 2.4 yrs 2)ONLY curative therapy that preserves FERTILITY!
English
2
8
28
2.7K
Robert Brodsky
Robert Brodsky@DocsDock200·
3) Engraftment > 90% even in pediatric patients possibly overcoming the reduced engraftment observed with thiotepa in haploBMT. 4) able to withdraw immunosuppression after 6mos 5) median hosp stay in adults - just 12 days! @ASH_hematology @BloodPortfolio
English
0
2
6
890
Robert Brodsky
Robert Brodsky@DocsDock200·
Nothing like puppy love.
Robert Brodsky tweet mediaRobert Brodsky tweet media
English
1
2
13
573
Robert Brodsky
Robert Brodsky@DocsDock200·
Five former ASH presidents in NYC @NYASciences for great symposium on sickle cell disease. One of them 🙁 still doesn't know how to wear a name tag.@ASH_hematology
Robert Brodsky tweet media
English
3
2
53
5.1K
Robert Brodsky
Robert Brodsky@DocsDock200·
The procedure would greatly expand the pool of potential donors, in addition to costing less than one-quarter of the price of innovative gene therapies. Source: Axios search.app/qV26Ke9E6k7qVZ…
English
0
1
17
1.2K
Robert Brodsky retweetledi
Taha A, MD, MBA
Taha A, MD, MBA@Taha_CancerDoc·
Almost every patient can have a haplo donor available, now we can say this approach is safe and effective for sickle cell disease. While gene therapies are effective too, access and cost (here and globally) will be major issues #bmtsm
Robert Brodsky@DocsDock200

Out in NEJM Evidence today. KEY TAKEAWAYS •Of 42 people with severe SCD who had the procedure , 95% were alive at 2 yrs, and 88% are considered cured. •Most people with SCD are eligible, which costs a fraction of the price of gene editing/therapy #casgevy @ASH_hematology

English
1
2
16
3K
Robert Brodsky
Robert Brodsky@DocsDock200·
Stay tuned! We already developed an even less toxic prep that allows us to stop immunosuppression in 6mos and PRESERVES FERTILITY in many. Game changer.
English
1
2
16
771
Robert Brodsky
Robert Brodsky@DocsDock200·
Out in NEJM Evidence today. KEY TAKEAWAYS •Of 42 people with severe SCD who had the procedure , 95% were alive at 2 yrs, and 88% are considered cured. •Most people with SCD are eligible, which costs a fraction of the price of gene editing/therapy #casgevy @ASH_hematology
Robert Brodsky tweet media
English
4
40
141
19.2K